$ARQT 3 SEC Filings

Filed On	Filing
17 Jul 2026	Form 3: Peetz Christopher, Director Holds 187,500 shares of Common Stock
08 Dec 2025	Form 3: Munshi Amit, Director Holds 2,000 shares of Common Stock
07 May 2025	Form 3: Vairavan Latha, SVP Chief Financial Officer Holds 45,104 shares of Common Stock
11 Apr 2024	Form 3: Topper David Joseph, Chief Financial Officer
03 Oct 2023	Form 3: Edwards Larry Todd, Chief Commercial Officer No securities owned
05 Sep 2023	Form 3: Smither John W, Chief Financial Officer Holds 141,392 shares of Common Stock
06 Sep 2022	Form 3: Krishnamohan Neha, Director Holds 1,232 shares of Common Stock
05 Jan 2022	Form 3: Matsuda Masaru, SVP and General Counsel No securities owned
07 Sep 2021	Form 3: Leonard Keith R, Director Holds 2,500 shares of Common Stock
16 Jun 2021	Form 3: Lin Sue-jean, Director Holds 300 shares of Common Stock
05 Apr 2021	Form 3: Burrows Scott L, Chief Financial Officer Holds 35,239 shares of Common Stock
19 Jan 2021	Form 3: Moore Matthew Richard, SVP and Chief Business Officer No securities owned
04 Nov 2020	Form 3: Curran Terrie, Director No securities owned
05 Aug 2020	Form 3: Burnett Patrick, See Remarks No securities owned
01 May 2020	Form 3: Gilbert Halley E, Director No securities owned
30 Jan 2020	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 5 others
30 Jan 2020	Form 3: Osborne David W, Chief Technical Officer Holds 254,288 shares of Common Stock
30 Jan 2020	Form 3: Sun Ricky, Director No securities owned
30 Jan 2020	Form 3: Welgus Howard G., Chief Medical Officer Holds 144,882 shares of Common Stock
30 Jan 2020	Form 3: Watanabe Todd Franklin, Director Holds 378,483 shares of Common Stock

Comments